From the Department of Plastic Surgery, University of South Florida Morsani College of Medicine.
Department of Health Outcomes and Behavior, University of South Florida Morsani College of Medicine.
Ann Plast Surg. 2022 Jun 1;88(5 Suppl 5):S439-S442. doi: 10.1097/SAP.0000000000003165. Epub 2022 Apr 23.
We sought to compare the safety profile of prepectoral breast reconstruction with total submuscular tissue expander reconstruction, previously our standard. Primary outcomes of interest in this retrospective cohort study were incidence of infection, hematoma, seroma, mastectomy flap necrosis, and reconstruction loss.
Total submuscular and prepectoral with acellular dermal matrix reconstructions consecutively performed by a single surgeon (P.D.S.) between January 1, 2016, and December 31, 2019, were compared. Demographic and clinical characteristics, as well as complications and complication types, were extracted for all patients. A t test was used to assess differences in continuous variables. Multivariate logistics regression was used to assess the association between type of reconstruction and complication rate. The statistical significance was set at 0.05 for all comparisons.
A total of 133 patients (234 breasts) were included. There was a significantly greater incidence of infection (16.5% vs 5.5%, P < 0.01) in the prepectoral/acellular dermal matrix cohort. However, reconstructive loss was low in both cohorts (2.5% and 3.0%, P = 0.83). Adjusted odds ratio for complications in the prepectoral cohort was 2.26, but this was not statistically significant (adjusted P = 0.24).
Prepectoral breast reconstruction shares an overall complication profile that is not greater than that of total submuscular reconstruction. It is associated with a greater risk of infection; however, the ability to salvage the reconstruction with early, aggressive intervention results in low rates of reconstructive loss, comparable with those of total submuscular reconstruction.
我们旨在比较胸肌前置乳房重建与全肌下组织扩张器重建的安全性,后者是我们的标准术式。本回顾性队列研究的主要观察指标为感染、血肿、血清肿、乳房皮瓣坏死和重建失败的发生率。
比较了 2016 年 1 月 1 日至 2019 年 12 月 31 日期间由同一位外科医生(P.D.S.)连续进行的全肌下和胸肌前置带脱细胞真皮基质重建。提取所有患者的人口统计学和临床特征,以及并发症和并发症类型。采用 t 检验评估连续变量的差异。采用多变量逻辑回归评估重建类型与并发症发生率之间的关联。所有比较的统计显著性均设定为 0.05。
共纳入 133 例患者(234 侧乳房)。胸肌前置/脱细胞真皮基质组感染发生率显著更高(16.5% vs. 5.5%,P < 0.01)。然而,两组的重建失败率均较低(2.5%和 3.0%,P = 0.83)。胸肌前置组并发症的调整后优势比为 2.26,但无统计学意义(调整后 P = 0.24)。
胸肌前置乳房重建的总体并发症谱与全肌下重建无显著差异。它与感染风险增加相关;然而,通过早期积极干预来挽救重建可导致较低的重建失败率,与全肌下重建相当。